Pharmafile Logo
Pharmafocus logo
Advanced Search

Ebola

Showing 15 posts of 53 posts found.

sag_ebola

Scientists develop treatment for all strains of Ebola

January 10, 2019
Research and Development Ebola, primates, research UTMB, texas, zmapp

Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects …

News
20441424453_40a90aa0b3_k

Ebola outbreak in Congo may last another 6 months, WHO officials say

November 14, 2018
Research and Development Congo, Ebola, WHO, health, infectious diseases

The outbreak of Ebola in the Democratic Republic of Congo (DRC) is expected to last until mid-2019, a World Health …

News
congo-river

MSD’s experimental vaccine to be used in fight against Congo Ebola outbreak

August 8, 2018
Research and Development Congo, Ebola, MSD, Merck, Vaccine, pharma

MSD’s experimental drug rVSV-ZEBOV will be used in tackling the latest Ebola outbreak in the Democratic Republic of Congo, after …

News
pharmafocus_june_2018_cover

The June 2018 issue of Pharmafocus is now live!

May 31, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma

The new June edition of Pharmafocus is now available to read online.

News
ebola

Ebola threat intensifies in DR Congo

May 18, 2018
Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …

News
prevail_-_ebola_vaccination

Trials reveal two strong vaccine candidates for Ebola

October 16, 2017
Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical

Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …

News
gsk-house-location-building

GSK proposes biopreparedness unit to combat global outbreaks

September 9, 2016
Medical Communications, Research and Development Ebola, GSK, Zika

London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …

News
GAVI logo

MSD and GAVI agree Ebola vaccine deal

January 20, 2016
Manufacturing and Production, Research and Development Ebola, GAVI, MSD, WHO

MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof  an Ebola virus vaccine, to …

News
China manufacturing

China’s Tianjin invests $300m in Ebola plant

October 20, 2015
Manufacturing and Production China, Ebola, Ebola vaccine, manufacturing, production, vaccines

China’s Tianjin CanSino Biotechnology, a developer of affordable vaccines, says that it will invest 2 billion Yuan (£203.3 million) in …

News
Ebola virus

Researchers hopeful experimental antiviral treatment stops Ebola

August 26, 2015
Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp

An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …

News
WHO flag

Encouraging first results from trial of Merck’s Ebola vaccine

July 31, 2015
Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …

News
Merck image

Merck Ebola vaccine safe and effective in latest trials

April 2, 2015
Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink

Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …

News
Merck image

Merck and NewLink Ebola vaccine trial begins

March 6, 2015
Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV

Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …

News
Ebola image

ZMapp trials start in Liberia

March 2, 2015
Research and Development, Sales and Marketing Africa, Ebola, Mapp, Vaccine, liberia, zmapp

Clinical trials to test the safety and efficacy of the experimental Ebola vaccine ZMapp are underway in infected parts of …

News
Ebola vaccine image

Scientists warn Ebola virus is mutating

January 29, 2015
Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, Institut Pasteur, J&J, JJ, guinea

Researchers in France studying the Ebola epidemic say the virus has mutated making it potentially even more contagious. Scientists based …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023